This pattern is similar to other studies in obese children and adolescents, in which low serum adiponectin levels were associated with markers of MetS, such as hyperglycemia, hyperinsulinemia, high blood pressure, and dyslipidemia (2,25,30). Here, ADIPOQ is linked to Hyperglycemia.